ENANTA PHARMACEUTICALS INC — Director's Dealing 2021

Dec 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ENANTA PHARMACEUTICALS INC (ENTA)
CIK: 0001177648
Period of Report: 2021-12-01

Reporting Person: Adda Nathalie (Sr. VP & Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-01	Common Stock	F	842	$87.68	Disposed	32902	Direct
2021-12-01	Common Stock	M	8750	$43.46	Acquired	41652	Direct
2021-12-01	Common Stock	M	4773	$48.52	Acquired	46425	Direct
2021-12-01	Common Stock	S	1587	$84.81	Disposed	44838	Direct
2021-12-01	Common Stock	S	5736	$85.49	Disposed	39102	Direct
2021-12-01	Common Stock	S	2700	$86.45	Disposed	36402	Direct
2021-12-01	Common Stock	S	1500	$87.60	Disposed	34902	Direct
2021-12-01	Common Stock	S	900	$88.31	Disposed	34002	Direct
2021-12-01	Common Stock	S	899	$89.33	Disposed	33103	Direct
2021-12-01	Common Stock	S	201	$90.17	Disposed	32902	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-01	Stock Option (Right to Buy)	$43.46	M	8750	Disposed	2025-06-29	Common Stock (8750)	Direct
2021-12-01	Stock Option (Right to Buy)	$48.52	M	4773	Disposed	2027-11-17	Common Stock (4773)	Direct

Footnotes

F1: Represents the number of shares of ENTA common stock forfeited by the reporting person to cover withholding taxes due as a result of settlement of a portion of the restricted stock unit award granted on November 20, 2020.

F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in May 2021.

F3: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $84.43 to $84.98, inclusive.

F4: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $85.04 to $85.98, inclusive.

F5: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $86.03 to $86.91, inclusive.

F6: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $87.23 to $87.92, inclusive.

F7: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $88.01 to $88.90, inclusive.

F8: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $89.02 to $89.88, inclusive.

F9: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $90.00 to $90.25, inclusive.

F10: 100% of the shares subject to the option are fully vested and exercisable.